CD274 and pneumonitis: Overall incidence of pneumonitis associated with anti‐PD‐1/PDL1 agents was approximately 3% in a meta‐analyses published by Wang et al. in 2017,55 and the incidence of high‐grade pneumonitis was 1.53%.56